Packaging and Labeling in Pharmaceutical Product Development - Best Practices
Learn how packaging and labeling fit into pharmaceutical product development, what regulators require, and how to prevent errors, delays and recalls.
Speaker
Michael Esposito
GMP training consultant · 30+ years in pharma
Overview
Packaging and labeling link a product's conception to its realization and distribution, and they are central to regulatory compliance. Yet their importance is often underestimated during planning, leading to longer cycle times, costly errors, delayed availability or recalls.
This 90-minute pharmaceutical packaging and labeling training covers regulatory agency requirements, SOPs and change control for packaging, how packaging and labeling interact, and how the package is created, including codes.
You'll also look at common packaging and labeling errors, supply chain issues and special cases such as product launches and clinical vs commercial packaging.
Why attend: Understanding where packaging and labeling sit in the wider development process helps you avoid delays and noncompliance and anticipate obstacles from marketing, medical affairs, regulatory, legal or QA. The session suits operations, regulatory, packaging, labeling, QA, production control, engineering, project management and sales and marketing teams.
What’s covered
- Regulatory agency requirements
- SOPs and change control for packaging
- How packaging and labeling interact
- Creating the package
- Codes
- Packaging errors
- Labeling errors
- Supply chain issues
- Special considerations: product launches and clinical vs commercial packaging
Who should attend
What you get
About the speaker
Michael Esposito has over 30 years’ experience in the pharmaceutical industry and 17 years’ experience in GMP training and document management. He has worked for Wyeth Pharmaceuticals, Pfizer, and Johnson & Johnson's Consumer Healthcare Division in a variety of areas including Packaging, project administration, Quality Assurance, Government Contracts, translations, systems training, and international operations. He collaborated in the development and implementation of the training portion of the Consent Decree workplan for Johnson & Johnson Consumer Healthcare and revised their introductory GMP course. He is a member of the training organizations GMP Training Educators Association and Association for GXP Excellence and is fully fluent in Spanish. His areas of interest include systems training, training effectiveness, post-training user support, process improvement, product security, and sustainable packaging.
More in FDA Compliance
See all 46 FDA webinars →
Carolyn Troiano · 90 min
Excel Spreadsheets; Develop and Validate for 21 CFR Part 11 Compliance
David Nettleton · 75 min
Major cGMP Issues: FDA Concerns in 2026
Ms. Michael Redmond · 60 min
Performance of Root Cause Analysis, CAPA, and Effectiveness Checks
Meredith Crabtree · 90 min